Davis, CA, United States of America

Gaurav Bharadwaj

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaurav Bharadwaj. Retrieved from https://idiyas.com/inventor/gaurav-bharadwaj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gaurav Bharadwaj: Innovator in Hybrid Telodendrimers

Introduction

Gaurav Bharadwaj is an accomplished inventor based in Davis, California. He has made significant contributions to the field of nanotechnology, particularly through his work on hybrid telodendrimers.

Latest Patents

Gaurav holds a patent for "Hybrid telodendrimers." This patent encompasses methods and compositions for hybrid telodendrimers and nanocarriers that utilize these innovative structures. His work in this area is paving the way for advancements in drug delivery systems.

Career Highlights

Gaurav Bharadwaj is affiliated with the University of California, where he continues to engage in groundbreaking research. His dedication to innovation is evident in his patent and ongoing projects.

Collaborations

Some of Gaurav's notable coworkers include Kit S Lam and Yuanpei Li. Their collaborative efforts contribute to the advancement of research in their respective fields.

Conclusion

Gaurav Bharadwaj is a prominent figure in the realm of hybrid telodendrimers, and his work is instrumental in advancing nanotechnology. His contributions are expected to have a lasting impact on the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…